First Time Loading...

ReproCell Inc
TSE:4978

Watchlist Manager
ReproCell Inc Logo
ReproCell Inc
TSE:4978
Watchlist
Price: 133 JPY -2.21% Market Closed
Updated: May 15, 2024
Financials Section:
Income Statement Balance Sheet Cash Flow Statement

Balance Sheet

8.4B
-0.6%
Assets
Growth Rates:
1 Year
+1%
3 Years
+39%
5 Years
+10%
7 Years
+18%
10 Years
+182%
627.4m
-5%
Liabilities
Growth Rates:
1 Year
+13%
3 Years
+13%
5 Years
+66%
7 Years
+30%
10 Years
+166%
7.7B
-0.2%
Equity
Growth Rates:
1 Year
0%
3 Years
+42%
5 Years
+7%
7 Years
+17%
10 Years
+184%

Balance Sheet Decomposition
ReproCell Inc

8.4B
Assets
627.4m
Liabilities
8.4B
Assets
627.4m
Liabilities
Current Assets 7.2B
Cash & Short-Term Investments 6.4B
Receivables 391.9m
Other Current Assets 466.9m
Non-Current Assets 1.1B
Long-Term Investments 960.6m
PP&E 126.8m
Intangibles 25.3m
Other Non-Current Assets 33.9m
Current Liabilities 580.1m
Accounts Payable 119.1m
Accrued Liabilities 4.8m
Other Current Liabilities 456.3m
Non-Current Liabilities 47.3m
Other Non-Current Liabilities 47.3m

Balance Sheet
ReproCell Inc

Rotate your device to view
Balance Sheet
Currency: JPY
Mar-2014 Mar-2015 Mar-2016 Mar-2017 Mar-2018 Mar-2019 Mar-2020 Mar-2021 Mar-2022 Mar-2023
Assets
Cash & Cash Equivalents
5 171
2 918
3 409
3 413
3 573
4 113
4 586
2 601
2 642
1 915
Cash Equivalents
5 171
2 918
3 409
3 413
3 573
4 113
4 586
2 601
2 642
1 915
Short-Term Investments
0
2 000
2 000
2 000
2 000
1 600
600
2 000
2 000
4 465
Total Receivables
67
115
133
126
132
170
153
180
348
446
Accounts Receivables
67
115
133
126
132
170
153
180
348
446
Other Receivables
0
0
0
0
0
0
0
0
0
0
Inventory
69
235
272
322
243
234
249
307
259
234
Other Current Assets
36
92
47
50
31
85
143
156
130
123
Total Current Assets
5 343
5 360
5 861
5 911
5 980
6 202
5 731
5 245
5 379
7 182
PP&E Net
16
48
62
96
72
179
188
174
98
101
PP&E Gross
16
48
62
96
72
179
188
174
98
101
Accumulated Depreciation
112
495
543
523
170
271
242
200
82
73
Intangible Assets
3
756
560
412
1
6
21
18
13
1
Goodwill
0
1 352
1 345
1 058
0
107
22
19
16
14
Long-Term Investments
50
63
106
347
535
930
538
543
2 540
1 005
Other Long-Term Assets
6
15
34
32
9
67
54
49
49
52
Other Assets
0
1 352
1 345
1 058
0
107
22
19
16
14
Total Assets
5 419
N/A
7 594
+40%
7 968
+5%
7 854
-1%
6 598
-16%
7 490
+14%
6 553
-13%
6 047
-8%
8 095
+34%
8 356
+3%
Liabilities
Accounts Payable
49
61
105
84
71
93
75
146
293
207
Accrued Liabilities
4
5
6
5
6
7
8
9
12
8
Short-Term Debt
0
0
5
3
0
0
0
0
0
0
Current Portion of Long-Term Debt
0
0
0
0
2
0
0
0
80
0
Other Current Liabilities
83
232
339
190
182
230
324
398
442
535
Total Current Liabilities
136
299
456
282
261
330
407
553
827
750
Long-Term Debt
80
80
86
83
80
80
80
80
0
0
Deferred Income Tax
1
123
151
114
1
1
0
15
10
23
Minority Interest
0
0
0
0
0
1
8
7
0
0
Other Liabilities
7
7
8
7
7
7
8
8
8
8
Total Liabilities
223
N/A
509
+128%
700
+38%
486
-31%
349
-28%
420
+20%
502
+20%
663
+32%
845
+27%
781
-8%
Equity
Common Stock
2 634
3 816
4 913
5 490
6 010
6 719
6 767
6 802
1 715
2 024
Retained Earnings
958
1 471
3 517
4 421
6 575
7 150
8 219
9 032
745
515
Additional Paid In Capital
3 518
4 699
5 796
6 344
6 863
7 572
7 619
7 654
6 313
6 082
Unrealized Security Profit/Loss
0
2
0
3
5
12
17
34
18
19
Treasury Stock
1
1
0
1
1
1
1
1
1
1
Other Equity
2
45
80
41
44
58
99
73
50
33
Total Equity
5 195
N/A
7 085
+36%
7 268
+3%
7 369
+1%
6 248
-15%
7 070
+13%
6 051
-14%
5 384
-11%
7 251
+35%
7 575
+4%
Total Liabilities & Equity
5 419
N/A
7 594
+40%
7 968
+5%
7 854
-1%
6 598
-16%
7 490
+14%
6 553
-13%
6 047
-8%
8 095
+34%
8 356
+3%
Shares Outstanding
Common Shares Outstanding
48
52
57
61
64
71
71
72
82
85

See Also

Summary
Intrinsic value, competitors valuation, and company profile.
DCF Valuation
Stock valuation using Discount Cash Flow valuation method.
Relative Valuation
Stock valuation using valuation multiples.
Wall Street Estimates
Price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
Stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Join more than 137,500+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.